BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 12351637)

  • 1. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
    Kobayashi T; Tanaka K; Inoue K; Kakizuka A
    J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
    Noguchi M; Takata T; Kimura Y; Manno A; Murakami K; Koike M; Ohizumi H; Hori S; Kakizuka A
    J Biol Chem; 2005 Dec; 280(50):41332-41. PubMed ID: 16234241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
    Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
    J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
    Ballar P; Shen Y; Yang H; Fang S
    J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
    Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
    J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.
    Fujita K; Nakamura Y; Oka T; Ito H; Tamura T; Tagawa K; Sasabe T; Katsuta A; Motoki K; Shiwaku H; Sone M; Yoshida C; Katsuno M; Eishi Y; Murata M; Taylor JP; Wanker EE; Kono K; Tashiro S; Sobue G; La Spada AR; Okazawa H
    Nat Commun; 2013; 4():1816. PubMed ID: 23652004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C.
    Dong M; Bridges JP; Apsley K; Xu Y; Weaver TE
    Mol Biol Cell; 2008 Jun; 19(6):2620-30. PubMed ID: 18400946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
    Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
    BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
    Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
    J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
    Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
    J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ER-associated degradation via p97/VCP-interacting motif.
    Ballar P; Fang S
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.
    Ye Y; Meyer HH; Rapoport TA
    Nature; 2001 Dec; 414(6864):652-6. PubMed ID: 11740563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
    Wang Y; Wan B; Zhou J; Li R; Yu L
    Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S; Fu QS; Zhao J; Hu HY
    Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
    Laço MN; Cortes L; Travis SM; Paulson HL; Rego AC
    PLoS One; 2012; 7(9):e43563. PubMed ID: 22970133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
    Vij N
    J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.